Pfizer's Boardroom Battle: A Closer Look
Imagine this: a big pharma company like Pfizer is in the spotlight, not for a new drug, but for some serious boardroom drama. Activist investor group Starboard Value has accused Pfizer of some heavy-handed tactics. They claim that Pfizer or its advisors threatened former CEO Ian Read and ex-CFO Fran